BRPI0607773A2 - método para produção de um oligÈmero de proantocianidina - Google Patents
método para produção de um oligÈmero de proantocianidinaInfo
- Publication number
- BRPI0607773A2 BRPI0607773A2 BRPI0607773-0A BRPI0607773A BRPI0607773A2 BR PI0607773 A2 BRPI0607773 A2 BR PI0607773A2 BR PI0607773 A BRPI0607773 A BR PI0607773A BR PI0607773 A2 BRPI0607773 A2 BR PI0607773A2
- Authority
- BR
- Brazil
- Prior art keywords
- ring structure
- oligomer
- substance
- composition
- resorcinol
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
- A61K36/04—Rhodophycota or rhodophyta (red algae), e.g. Porphyra
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/14—Cupressaceae (Cypress family), e.g. juniper or cypress
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/485—Gueldenstaedtia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/60—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2
- C07D311/62—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2 with oxygen atoms directly attached in position 3, e.g. anthocyanidins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Birds (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Biochemistry (AREA)
- Hospice & Palliative Care (AREA)
- Toxicology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Cosmetics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
MéTODO PARA PRODUçãO DE UM OLIGÈMERO DE PROANTOCIANIDINA. A presente invenção refere-se a uma composição contendo como seu principal componente um oligómero de proantocianidina, ao qual se liga uma substância apresentando uma estrutura de anel de floroglicinol ou estrutura de anel de resorcinol, a qual reduz o peso molecular e que é obtida através do aquecimento de materiais de plantas contendo o polímero de proantocianidina ou extrato do mesmo, com uma substância apresentando uma estrutura de anel de floroglicinol ou estrutura de anel de resorcinol em uma solução aquosa acídica, a um método de produção da dita composição, e ao uso da dita composição em produtos para preservação da saúde e produtos farmacêuticos. De acordo com a invenção, o oligómero de proantocianidina tendo atividade fisiológica, ao qual uma substância apresentando uma estrutura de anel de floroglicinol ou estrutura de anel de resorcinol, se liga e tem peso molecular reduzido em um tal nível que o oligómero possa ser absorvido no corpo humano, o que foi convencionalmente difícil de se obter com alta produção de matérias-primas de plantas, pode ser eficiente e facilmente produzido.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005-051070 | 2005-02-25 | ||
JP2005051070 | 2005-02-25 | ||
PCT/JP2006/303402 WO2006090830A1 (ja) | 2005-02-25 | 2006-02-24 | プロアントシアニジンオリゴマーの製造方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
BRPI0607773A2 true BRPI0607773A2 (pt) | 2009-10-06 |
BRPI0607773B1 BRPI0607773B1 (pt) | 2019-07-23 |
Family
ID=36927463
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0607773-0A BRPI0607773B1 (pt) | 2005-02-25 | 2006-02-24 | Método para produção de um oligômero de proantocianidina |
Country Status (14)
Country | Link |
---|---|
US (2) | US20090047305A1 (pt) |
EP (1) | EP1852430B1 (pt) |
JP (1) | JP4941991B2 (pt) |
KR (2) | KR20130128017A (pt) |
CN (1) | CN101133043B (pt) |
AU (1) | AU2006216182A1 (pt) |
BR (1) | BRPI0607773B1 (pt) |
CA (1) | CA2599295C (pt) |
DK (1) | DK1852430T3 (pt) |
ES (1) | ES2746955T3 (pt) |
NZ (1) | NZ560436A (pt) |
PL (1) | PL1852430T3 (pt) |
RU (1) | RU2435579C2 (pt) |
WO (1) | WO2006090830A1 (pt) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2006216182A1 (en) | 2005-02-25 | 2006-08-31 | Amino Up Chemical Co., Ltd. | Method of producing proanthocyanidin oligomer |
JP2008156265A (ja) * | 2006-12-22 | 2008-07-10 | Yamagata Prefecture | A型プロアントシアニジンオリゴマー画分及びその製造方法 |
JP5160149B2 (ja) * | 2007-06-22 | 2013-03-13 | 明治薬品株式会社 | 柿ポリフェノールオリゴマー |
FR2923718B1 (fr) * | 2007-11-15 | 2009-12-18 | Caudalie | Compositions de derives polyphenoliques flavonoidiques et leurs applications pour lutter contre les pathologies et le vieillissement des organismes vivants |
US20110027399A1 (en) * | 2008-03-31 | 2011-02-03 | Hiroshima University | Antiviral Agent and Antiviral Composition |
CN102083444A (zh) * | 2008-05-09 | 2011-06-01 | 西奈山医学院 | 用于预防和治疗神经退行性疾病的方法 |
JP5856728B2 (ja) * | 2009-07-21 | 2016-02-10 | 国立大学法人金沢大学 | ポリフェノールを配合してなる経口投与用又は外用組成物、並びにその用途 |
CN102224923B (zh) * | 2011-04-26 | 2012-08-08 | 乌鲁木齐富润东方生物科技有限公司 | 一种改性苹果多酚的制备方法 |
BR112013029888A2 (pt) * | 2011-05-27 | 2017-08-08 | Unilever Nv | composição oral para prevenir ou tratar aterosclerose, método para prevenir ou tratar aterosclerose e uso da composição |
WO2012163588A2 (en) | 2011-05-27 | 2012-12-06 | Unilever Plc | Anti-ageing composition |
CN103561768B (zh) * | 2011-05-27 | 2016-11-16 | 荷兰联合利华有限公司 | 抗炎组合物 |
CN102433125A (zh) * | 2011-08-31 | 2012-05-02 | 新疆富润贸易有限公司 | 一种改性葡萄籽多酚及其制备方法 |
JP2013087102A (ja) * | 2011-10-20 | 2013-05-13 | Hiroshima Univ | バナナ等抽出物を有効成分とする非エンベロープウイルスに対する抗ウイルス剤 |
JP6047812B2 (ja) * | 2011-10-20 | 2016-12-21 | 国立大学法人広島大学 | カリン等抽出物を有効成分とするノロウイルス属に属する非エンベロープウイルスに対する抗ウイルス剤 |
CN102617535B (zh) * | 2012-02-24 | 2014-08-20 | 浙江大学 | 从杨梅叶中提取原飞燕草素的方法 |
CN102924422B (zh) * | 2012-09-10 | 2015-03-11 | 华南理工大学 | 脉冲电场强化降解制备低聚原花青素的方法 |
WO2014054174A1 (ja) * | 2012-10-05 | 2014-04-10 | フジッコ株式会社 | 低重合度プロアントシアニジンの製法およびそれにより得られる低重合度プロアントシアニジン |
CN103183967A (zh) * | 2013-04-28 | 2013-07-03 | 湖南农业大学 | 一种以新鲜樟树果皮生产紫色素的方法 |
TW201733605A (zh) * | 2016-02-29 | 2017-10-01 | 明治股份有限公司 | 可可水萃物、含它之飲食品、可可萃取物之製造方法、及多酚之萃取方法 |
EP3677577A4 (en) * | 2017-08-28 | 2021-04-28 | NBC Meshtec, Inc. | POLYPHENOL PRODUCTION PROCESS |
CN108299370B (zh) * | 2018-04-09 | 2021-12-07 | 上海永姿化妆品有限公司 | 一种用于护肤乳液的生物抗氧化剂的合成方法 |
JP7210190B2 (ja) * | 2018-08-28 | 2023-01-23 | セッツ株式会社 | 抗ノロウイルス剤、消毒剤及び洗浄剤 |
CN111034902B (zh) * | 2019-12-13 | 2023-03-28 | 汕头大学 | 一种高稳定性的色素衍生物及其制备方法 |
WO2022205137A1 (zh) * | 2021-03-31 | 2022-10-06 | 贝尔克斯生技股份有限公司 | 高聚原花青素组合物及其应用 |
WO2022241749A1 (zh) * | 2021-05-21 | 2022-11-24 | 浙江大学 | 一种原飞燕草素b9没食子酸酯的化学合成方法 |
CN113429371B (zh) * | 2021-05-21 | 2022-06-21 | 浙江大学 | 一种原飞燕草素b9没食子酸酯的化学合成方法 |
KR20230114165A (ko) | 2022-01-24 | 2023-08-01 | 경희대학교 산학협력단 | 저분자 페놀 화합물을 포함하는 수소화 분해된 적송수피 추출물을 유효성분으로 함유하는 알츠하이머병 예방 또는 치료용 조성물 및 이의 제조방법 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60120818A (ja) * | 1983-12-01 | 1985-06-28 | Sanko Seibutsu Kagaku Kenkyusho:Kk | 健康茶 |
JPH0762014B2 (ja) | 1992-07-29 | 1995-07-05 | 株式会社北條製▲餡▼所 | プロアントシアニジンの製造方法 |
PL329325A1 (en) * | 1996-04-02 | 1999-03-29 | Mars Inc | Cocoa extract compounds, method of obtaining them and their application |
US6800433B1 (en) | 1999-04-23 | 2004-10-05 | Kyowa Hakko Kogyo Co., Ltd. | Process for purification of proanthocyanidin oligomer |
KR100509119B1 (ko) * | 1999-07-16 | 2005-08-18 | 주식회사 엘지생활건강 | 프로시아니딘 올리고머를 유효성분으로 하는 약제 |
KR100690980B1 (ko) * | 1999-07-16 | 2007-03-12 | 주식회사 벤스랩 | 콜레스테롤 분해용 음료 및 분해용 제재 |
FR2802812B1 (fr) * | 1999-12-22 | 2002-08-23 | Serobiologiques Lab Sa | Utilisation de residus issus de la fabrication du vin pour la fabrication de preparations cosmetiques et/ou pharmaceutiques. |
JP3595816B2 (ja) | 2002-04-24 | 2004-12-02 | 株式会社東洋新薬 | プロアントシアニジン含有物の製造方法 |
JP3568201B1 (ja) * | 2002-07-29 | 2004-09-22 | 株式会社東洋新薬 | 健康食品および健康飲料 |
JP5004265B2 (ja) * | 2003-05-26 | 2012-08-22 | 株式会社アミノアップ化学 | 含硫プロアントシアニジンオリゴマー組成物及びその製造方法 |
AU2006216182A1 (en) | 2005-02-25 | 2006-08-31 | Amino Up Chemical Co., Ltd. | Method of producing proanthocyanidin oligomer |
-
2006
- 2006-02-24 AU AU2006216182A patent/AU2006216182A1/en not_active Abandoned
- 2006-02-24 BR BRPI0607773-0A patent/BRPI0607773B1/pt active IP Right Grant
- 2006-02-24 DK DK06714541.7T patent/DK1852430T3/da active
- 2006-02-24 KR KR1020137028732A patent/KR20130128017A/ko not_active Application Discontinuation
- 2006-02-24 CN CN2006800060415A patent/CN101133043B/zh active Active
- 2006-02-24 JP JP2007504806A patent/JP4941991B2/ja active Active
- 2006-02-24 US US11/814,922 patent/US20090047305A1/en not_active Abandoned
- 2006-02-24 KR KR1020077019349A patent/KR101366187B1/ko active IP Right Grant
- 2006-02-24 WO PCT/JP2006/303402 patent/WO2006090830A1/ja active Application Filing
- 2006-02-24 NZ NZ560436A patent/NZ560436A/en unknown
- 2006-02-24 CA CA2599295A patent/CA2599295C/en active Active
- 2006-02-24 ES ES06714541T patent/ES2746955T3/es active Active
- 2006-02-24 PL PL06714541T patent/PL1852430T3/pl unknown
- 2006-02-24 EP EP06714541.7A patent/EP1852430B1/en active Active
- 2006-02-24 RU RU2007135274/04A patent/RU2435579C2/ru active
-
2015
- 2015-12-21 US US14/976,645 patent/US10183007B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
CA2599295A1 (en) | 2006-08-31 |
US10183007B2 (en) | 2019-01-22 |
JPWO2006090830A1 (ja) | 2008-07-24 |
US20160151329A1 (en) | 2016-06-02 |
KR101366187B1 (ko) | 2014-02-21 |
DK1852430T3 (da) | 2019-08-05 |
CN101133043A (zh) | 2008-02-27 |
WO2006090830A1 (ja) | 2006-08-31 |
KR20130128017A (ko) | 2013-11-25 |
KR20070110040A (ko) | 2007-11-15 |
CN101133043B (zh) | 2012-10-10 |
PL1852430T3 (pl) | 2020-03-31 |
CA2599295C (en) | 2014-10-14 |
ES2746955T3 (es) | 2020-03-09 |
EP1852430B1 (en) | 2019-07-03 |
NZ560436A (en) | 2011-03-31 |
AU2006216182A1 (en) | 2006-08-31 |
RU2007135274A (ru) | 2009-03-27 |
EP1852430A4 (en) | 2011-10-12 |
BRPI0607773B1 (pt) | 2019-07-23 |
EP1852430A1 (en) | 2007-11-07 |
RU2435579C2 (ru) | 2011-12-10 |
JP4941991B2 (ja) | 2012-05-30 |
US20090047305A1 (en) | 2009-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0607773A2 (pt) | método para produção de um oligÈmero de proantocianidina | |
Caro-Ordieres et al. | The coming age of flavonoids in the treatment of diabetic complications | |
BRPI0608840B8 (pt) | composição farmacêutica compreendendo uma difenil uréia substituída por ômega-carboxiarila, e seu processo de preparação | |
BRPI0717673B8 (pt) | composição de oligogalacturonanas, biomaterial e têxtil | |
BRPI0910832B8 (pt) | derivados de tienopiridona como ativadores de proteína quinase ativada por amp (ampk), seus usos, seu processo de preparação e seus intermediários, e medicamentos. | |
BRPI0910439B8 (pt) | derivados de tienopiridona como ativadores da proteína quinase ativada por amp (ampk), seu processo de preparação, e medicamentos | |
BRPI0821005A8 (pt) | Método para aumentar a eficiência da absorção de xantofilas e composição | |
CN104286842A (zh) | 一种解酒护肝的复方组合片 | |
Dixit Jr et al. | Lepidium sativum: Bone healer in traditional medicine, an experimental validation study in rats | |
Mattioli et al. | Tannins-based extracts: effects on gut chicken spontaneous contractility | |
RU2006108792A (ru) | Гликозид, имеющий скелет 4-метилэргост-7-ен-3-ола и агент, улучшающий гипергликемию | |
Lopes et al. | Camel Grass Phenolic Compounds: Targeting Inflammation and Neurologically Related Conditions | |
BR112021021557A2 (pt) | Corpos de cetona confinados em microesferas | |
Elango et al. | A Comparative Analysis of Commercial Metformin Tablets. | |
Omeje et al. | Effect of ethanol extract of Corchorus olitorus leaf on glucose level and antioxidant enzymes of Streptozotocin-induced hyperglycemic rat. | |
Peshina et al. | On classification of risks in agroindustrial complex | |
Moneim et al. | Effect of thymoquinone and camel milk on liver function of streptozotocin induced diabetic albino rats | |
HAN et al. | Prevention and treatment of cardio-cerebrovascular diseases by daidzein: research advances | |
Pulipati et al. | In vitro Anthelmintic Impact of Various Extracts of MANSOA ALLIACEAE BARK on Pheretima posthuma and in-silico Molecular Docking Evaluation of some Isolated Phytoconstituents | |
GAO | Application of borneol and menthol in promoting nanopreparations across physiological barriers | |
Zhou et al. | Research Progress in Ellagitannin Compounds | |
Pan et al. | Implantation of Gamma nail and proximal femoral nail for the treatment of femoral intertrochanteric fractures in the elderly: A randomized follow-up for 131 cases | |
Żyżyńska-Granica et al. | The anti-inflammatory activity of dietary flavonoid aglycones and their glucuronidated metabolites in human neutrophils (PMNs) and human umbilical vein endothelial cells (HUVECs) | |
Seyed Abdolhossein Mehdi et al. | Incidence and associated risk factors of birth fractures in the newborns | |
Bahiga Galal et al. | < The> impact of first aid program on school nurses' knowledge in Menoufiya governorate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B06I | Publication of requirement cancelled [chapter 6.9 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B25D | Requested change of name of applicant approved |
Owner name: NAGASAKI UNIVERSITY (JP) ; USAIEN PHARMACEUTICAL C |
|
B25G | Requested change of headquarter approved |
Owner name: NAGASAKI UNIVERSITY (JP) ; USAIEN PHARMACEUTICAL C |
|
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 23/07/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 23/07/2019, OBSERVADAS AS CONDICOES LEGAIS |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 24/02/2006 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |